18 August 10:05
Biofarm posted a net profit of 48.8 million lei in the first half of 2025, up 16.2% from 2024.
Raluca Ioana Draghici
Economy
Captură de ecran: Facebook/Biofarm: https://www.facebook.com/photo/?fbid=793664634410754&set=a.579071991003940&locale=ro_RO
In the first six months of 2025, Biofarm achieved a net profit of 48.8 million lei, representing a profit margin of almost 30%. The company remains committed to research and development, investing in innovation and market-tailored therapeutic solutions. Biofarm ranks second in the Consumer Healthcare segment with six leading brands. Controlled by Longshield Investment Group and Lion Capital, the company has two factories in Bucharest and a portfolio of over 100 products.
Sources
Biofarm are marjă de profit net de circa 30% în primul semestru la vânzări de peste 162 de milioane de lei
Bursă. Producătorul de medicamente Biofarm a încheiat S1/2025 cu profit net de aproape 49 mil. lei, în creştere cu 16% an/an. Veniturile s-au majorat cu 15%, până la 163 mil. lei
ȘTIRI PE ACELEAȘI SUBIECTE
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
